Attached files
| file | filename |
|---|---|
| 10-K - 10-K - DEXCOM INC | dxcm-12312016x10k.htm |
| EX-32.02 - EXHIBIT 32.02 - DEXCOM INC | dxcm12312016ex3202.htm |
| EX-32.01 - EXHIBIT 32.01 - DEXCOM INC | dxcm12312016ex3201.htm |
| EX-31.02 - EXHIBIT 31.02 - DEXCOM INC | dxcm12312016ex3102.htm |
| EX-31.01 - EXHIBIT 31.01 - DEXCOM INC | dxcm12312016ex3101.htm |
| EX-21.01 - EXHIBIT 21.01 - DEXCOM INC | dxcm123116ex2101.htm |
| EX-10.43 - EXHIBIT 10.43 - DEXCOM INC | dxcm12312016ex1043.htm |
| EX-10.42 - EXHIBIT 10.42 - DEXCOM INC | dxcm12312016ex1042.htm |
Exhibit 23.01
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements:
(1) | Registration Statements (Form S-3 Nos. 333-199994, 333-206619, and 333-211101) of DexCom, Inc., and |
(2) | (Registration Statements (Form S-8 Nos. 333-124059, 333-138174, 333-145159, 333-149734, 333-158993, 333-166552, 333-172604, 333-180421, 333-188305, 333-195660, 333-202375, and 333-204699) pertaining to the 2005 Equity Incentive Plan, 2005 Employee Stock Purchase Plan, and 1999 Stock Option Plan, 2015 Equity Incentive Plan, 2015 Employee Stock Purchase Plan of DexCom, Inc.; |
of our reports dated February 28, 2017, with respect to the consolidated financial statements and schedule of Dexcom, Inc., and the effectiveness of internal control over financial reporting of DexCom, Inc., included in this Annual Report (Form 10-K) of DexCom, Inc. for the year ended December 31, 2016.
/s/ Ernst & Young LLP
San Diego, California
February 28, 2017